Equine adipose mesenchymal stem cells (eq-ASCs) appear to have higher potential for migration and musculoskeletal differentiation.

The research article investigates the behavior of equine adipose-derived mesenchymal stem cells (eq-ASCs) in vitro and finds that these cells possess a strong capability for both migration and musculoskeletal differentiation, which is amplified through the treatment of TGFB3.

Research Objectives and Methodology

• The aim of this research was to explore certain behavioral aspects of eq-ASCs as grown in a laboratory setting. This was done with a view to understanding how these behaviors might affect the efficiency of stem cell therapy.
• The Mesenchymal Stem Cells (MSCs) were isolated from a donor horse and then expanded under normal culture conditions.

Findings from the Experiment

• After some time, these cells started to form aggregated structures, a change that was noticed with the increased expression of migratory-related genes. The genes in question included those of the transforming growth factor beta 1, its receptor 3, snail family transcriptional repressor 1, E-cadherin and β-catenin.
• The researchers also observed an increase in the expression of a musculoskeletal progenitor marker, scleraxis bHLH transcription factor, after three days.

Impact of TGFB Signaling Pathway

• To better understand the impact of the TGFB signaling pathway, the researchers made use of a gain- and loss-of-function treatment involving TGFB3 and SB431542, a TGFB inhibitor.
• They discovered that TGFB3 treatment exaggerated the aggregate formation effects, inducing the rearrangement of the cytoskeletal actin to some extent. Conversely, the inhibition of the TGFB signaling pathway by SB431542 reversed this phenomenon.

Overall Implications of the Findings

• The findings provide evidence that eq-ASCs have a natural capacity for migration, and this capacity is enhanced through TGFB3 treatment.
• This ability can play a significant role in cell motility and the healing of transplanted cells’ wounds.